Policy Revision - Clinical Coverage Policy 11A-15, Hematopoietic Stem-Cell Transplantation for Solid Tumors of Childhood

<p>Clinical Coverage Policy 11A-15, <em>Hematopoietic Stem-Cell Transplantation for Solid Tumors of Childhood</em>, has been revised.</p>

Author: Practitioners, Facilities and Policy Development

Clinical Coverage Policy 11A-15, Hematopoietic Stem-Cell Transplantation for Solid Tumors of Childhood, has been revised. The revisions, which will become effective Aug. 1, 2018, will add coverage criteria for the following:

  • Tandem autologous stem-cell transplants for high-risk neuroblastoma, and,
  • Single autologous stem-cell transplant for metastatic retinoblastoma.

Practitioners, Facilities and Policy Development
DMA, 919-855-4320

Related Topics: